HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,573-1,584 of 1,811
Behavioral study icon
CompletedNCT02900144

Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)

Official study title

Modified Comprehensive Behavioral Intervention for Tics: Treating Children With Tic Disorders, Co-occurring ADHD and Psychosocial Impairment

This study has finished and is no longer accepting participants.

In Boston
ADHDBehavioural studyAges 10–17
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00573248

Nicotine and Behavior in Adult ADHD

Official study title

Nicotine and Behavioral Regulation in Adult ADHD

This study has finished and is no longer accepting participants.

In Irvine
ADHDMedication studyAges 18–45
Countries
United States
Sponsor
University of California, Irvine
Drug study icon
CompletedNCT00914862

Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults

Official study title

A Comparative Single Dose Pharmacokinetic and Safety Study of 4 mg or 8 mg Ramelteon in Adolescents With Insomnia Characterized by Difficulty With Sleep Onset, Children With Insomnia Associated With ADHD, and Healthy Adults.

This study has finished and is no longer accepting participants.

Multiple locations, including Overland Park
ADHDMedication studyAges 6–50
Countries
United States
Sponsor
Takeda
Drug study icon
CompletedNCT04232644

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)

Official study title

A Pilot, Randomized, Double-Blind, Active-Controlled, 2-Treatment, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Abuse Liability of Dextroamphetamine Sulfate From an Abuse-Deterrent Immediate-Release Formulation (ADAIR)

This study has finished and is no longer accepting participants.

In Toronto
ADHDMedication studyAges 18–55
Countries
Canada
Sponsor
Vallon Pharmaceuticals, Inc.
Behavioral study icon
CompletedNCT05862727

Preschool Attention and Sleep Support (PASS)

Official study title

Preschool Attention and Sleep Support (PASS): A Telehealth Intervention for Children at Risk for ADHD

This study has finished and is no longer accepting participants.

In Durham
ADHDBehavioural studyAges 3–5
Countries
United States
Sponsor
Duke University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.